Craig R. Rayner
CIK 1834170 · PRESIDENT, INTEGRATED DRUG DEV · last filed 2021-09-07
Craig R. Rayner is a PRESIDENT, INTEGRATED DRUG DEV who has filed 4 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $2.0M of CERT on Sep 7, 2021. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.85M
1
4
-$4.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERT | PRESIDENT, INTEGRATED DRUG DEV | 316,210 | $5.84 | $1.85M | -$4.78M | 4 | 2021-09-07 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-07 | CERT | Sell (S) | −54,462 | -$1.98M | EDGAR |
| 2021-06-15 | CERT | Sell (S) | −108,924 | -$2.80M | EDGAR |
| 2021-06-15 | CERT | Grant (A) | +38,462 | $0 | EDGAR |
| 2021-04-09 | CERT | Grant (A) | +23,810 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.